Study (reference) | Mean age | Sepsis criteria | Healthy (μg/ml)a | Number of patients (healthy) | Sepsis (μg/ml)a | Number of patients (sepsis) |
---|---|---|---|---|---|---|
Neonates | Â | Â | Â | Â | Â | Â |
Figueras-Aloy and colleagues [49] | 0 to 14 days | SNAP-II | 580 (523 to 717) | 12 | 681 (541 to 757) | 15 |
Kourtis and colleagues [50] | 0 to 2 days | Clinical | 1,155 | 75 | 1,331 (1,123 to 1,427) | 14 |
Giannaki and colleagues [47] | At term |  | 674 ± 223 | 40 |  |  |
Rebuck and colleagues [43] | At term | Â | 463 (338 to 557) | 22 | Â | Â |
Koenig and colleagues [42] | 0 to 7 days |  | 324 ± 24 | 10 |  |  |
Children | Â | Â | Â | Â | Â | Â |
Kourtis and colleagues [59] | Children | Â | 3,356 (2,818 to 3,894) | 100 | Â | Â |
Briassoulis and colleagues [19] | 6.5 (2.8) | PRISM | 3,750 ± 321 | 10 | 6,263 ± 3,813 | 10 |
Adults | Â | Â | Â | Â | Â | Â |
Weigand and colleagues [66] | 58.7 (4.4) | ACCP/SCCM | 460 | 7 | 400 | 14 |
Kourtis and colleagues [50] | Adult | Â | 950 (700 to 1,220) | 75 | Â | Â |
Schleiffenbaum and colleagues [23] | Adult |  | 1,600 ± 800 | 63 |  |  |
Giannaki and colleagues [47] | Adult |  | 938 ± 181 | 40 |  |  |
Rebuck and colleagues [43] | Adult | Â | 717 (410 to 822) | 22 | Â | Â |
Koenig and colleagues [42] | Adult |  | 537 ± 28 | 9 |  |  |